glp-1 weight loss guidelines WHO Releases on Use for Obesity Treatment GLP-1 is only for severely

Nearly a year ago, she started on a class of weight loss medications called GLP-1 receptor agonists, which includes Ozempic, Wegovy and Mounjaro

GLP-1 (Glucagon-Like Peptide-1) therapy involves medications like Semaglutide (Wegovy, Ozempic) and Tirzepatide (Mounjaro) that help regulate appetite, improve blood sugar control, and support weight loss

Owing to the rising disposable incomes, patients are able to afford advanced diabetes and obesity treatments, contributing to the rapid growth of the market in the country

This inflammatory milieu may contribute to hepatic insulin resistance and thus establish a vicious circle